Scholarlink

Background <p>To find a useful non-invasive biomarker for evaluating treatment response to neoadjuvant immunochemotherapy (nICT) in patients with esophageal squamous cell carcinoma (ESCC), using spectral computed tomography (CT).</p> Methods <p>Spectral CT-derived parameters including the 40&#xa0;keV virtual monoenergetic imaging (VMI), iodine concentration (IC), and normalized iodine concentration (NIC) were obtained before and after nICT in 87 patients with ESCC. Independent samples t-test (normality) or Mann-Whitney U test (non-normality) was used to compare the differences of spectral CT-derived parameters between responders and non-responders. Binary logistic regression analysis was performed to identify independent predictive factors for responders. Diagnostic performance of parameters in predicting response was tested with receiver operating characteristic (ROC) curve analysis.</p> Results <p>The post-area, post-40&#xa0;keV VMI, post-IC, and post-NIC of the responders were significantly lower than those of the non-responders (<i>p</i> &lt; 0.001, &lt; 0.001, &lt; 0.001, and 0.002, respectively). Post-area (odds ratio [OR], 0.980, 95% confidence interval [95% CI], 0.970–0.990; <i>p</i> &lt; 0.001) and post-NIC (OR, 0.824, 95% CI, 0.723–0.938; <i>p</i> = 0.003) were independent post-treatment predictors of therapeutic efficacy. A predictive model combining post-NIC and post-area showed the most favorable diagnostic performance with an area under the curve of 0.844.</p> Conclusions <p>Post-NIC and post-area of tumor might serve as independent monitoring biomarkers for assessing pathological response to nICT in ESCC. The model combining post-NIC and post-area may provide preliminary imaging evidence for individualized clinical decisions.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Role of spectral CT in quantitative evaluation of pathologic response to neoadjuvant immunochemotherapy in esophageal squamous cell carcinoma: a pilot study

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年6月16日

查看全文
  • Huanhuan Zheng,
  • Yan Zhu,
  • MiaoMiao Li,
  • Qinglei Zhang,
  • Xiaolei Wei,
  • Xingbiao Chen,
  • Wei Ren,
  • Song Liu

摘要

Background

To find a useful non-invasive biomarker for evaluating treatment response to neoadjuvant immunochemotherapy (nICT) in patients with esophageal squamous cell carcinoma (ESCC), using spectral computed tomography (CT).

Methods

Spectral CT-derived parameters including the 40 keV virtual monoenergetic imaging (VMI), iodine concentration (IC), and normalized iodine concentration (NIC) were obtained before and after nICT in 87 patients with ESCC. Independent samples t-test (normality) or Mann-Whitney U test (non-normality) was used to compare the differences of spectral CT-derived parameters between responders and non-responders. Binary logistic regression analysis was performed to identify independent predictive factors for responders. Diagnostic performance of parameters in predicting response was tested with receiver operating characteristic (ROC) curve analysis.

Results

The post-area, post-40 keV VMI, post-IC, and post-NIC of the responders were significantly lower than those of the non-responders (p < 0.001, < 0.001, < 0.001, and 0.002, respectively). Post-area (odds ratio [OR], 0.980, 95% confidence interval [95% CI], 0.970–0.990; p < 0.001) and post-NIC (OR, 0.824, 95% CI, 0.723–0.938; p = 0.003) were independent post-treatment predictors of therapeutic efficacy. A predictive model combining post-NIC and post-area showed the most favorable diagnostic performance with an area under the curve of 0.844.

Conclusions

Post-NIC and post-area of tumor might serve as independent monitoring biomarkers for assessing pathological response to nICT in ESCC. The model combining post-NIC and post-area may provide preliminary imaging evidence for individualized clinical decisions.